These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3087294)

  • 1. [Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma].
    Kobayashi H; Sahashi M; Obata K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2147-54. PubMed ID: 3087294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
    Murahashi I; Mukae K; Tabata Y; Sakuma H; Kanbe K; Arai T; Kaneko K; Honda M; Maeda S; Takasaki E
    Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative treatment of FT-207 suppository in cervical cancer-- serum and tumor tissue content of FT-207].
    Nagai S; Sawada T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):307-11. PubMed ID: 6421248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M; Nagano H; Gunge N; Murei T; Iwamoto S; Seo Y; Yamamoto Y; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
    Murahashi I; Kanbe K; Kaneko K; Honda M; Maeda S; Takahashi E
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1781-8. PubMed ID: 6433803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue].
    Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Okuda M; Teramoto T; Yoshida H; Sato K; Ushijima Y; Uematsu Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1088-93. PubMed ID: 3922311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of tissue concentrations of FT-207 and 5-FU in head and neck cancer].
    Fukuyo K; Eura S; Nagano H; Kato T; Soda T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):967-72. PubMed ID: 6408992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributions of tegafur in tissues of gastric adenocarcinoma patients: tissue uptakes and concentrations in plasma after oral and rectal administrations.
    Arima S; Futami K; Yoshimura S; Shimura H
    Jpn J Clin Oncol; 1989 Sep; 19(3):237-41. PubMed ID: 2509764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
    Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
    Takeyama M; Honjoh M; Ohnishi N; Ishikawa Y; Sakaguchi H; Hanai J
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1953-9. PubMed ID: 8215468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma and tissue concentration of tegafur by a new soft capsule type suppository in colorectal carcinoma].
    Namba M; Muto K; Ikeguchi S; Shida S
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):47-52. PubMed ID: 2492183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.